Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 157

    1.

    Healthcare worker occupation and immune response to Pneumocystis jirovecii.

    Tipirneni R, Daly KR, Jarlsberg LG, Koch JV, Swartzman A, Roth BM, Walzer PD, Huang L.

    Emerg Infect Dis. 2009 Oct;15(10):1590-7.PMID: 19861050 [PubMed - in process]Related articlesFree article

    2.

    Evidence for high prevalence of Pneumocystis jirovecii exposure among Cameroonians.

    Nkinin SW, Daly KR, Walzer PD, Ndzi ES, Asonganyi T, Respaldiza N, Medrano FJ, Kaneshiro ES.

    Acta Trop. 2009 Nov;112(2):219-24. Epub 2009 Aug 7.PMID: 19665440 [PubMed - indexed for MEDLINE]Related articles

    3.

    Preclinical drug discovery for new anti-pneumocystis compounds.

    Cushion MT, Walzer PD.

    Curr Med Chem. 2009;16(20):2514-30.PMID: 19601796 [PubMed - in process]Related articles

    4.

    Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens.

    Daly K, Koch J, Respaldiza N, de la Horra C, Montes-Cano MA, Medrano FJ, Varela JM, Calderon EJ, Walzer PD.

    Clin Microbiol Infect. 2009 Oct;15(10):937-42. Epub 2009 Mar 21.PMID: 19416292 [PubMed - in process]Related articles

    5.

    Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice.

    Linke MJ, Ashbaugh AA, Koch JV, Levin L, Tanaka R, Walzer PD.

    J Eukaryot Microbiol. 2009 Jan-Feb;56(1):58-65.PMID: 19335775 [PubMed - indexed for MEDLINE]Related articles

    6.

    Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection.

    Walzer PD, Djawe K, Levin L, Daly KR, Koch J, Kingsley L, Witt M, Golub ET, Bream JH, Taiwo B, Morris A.

    J Infect Dis. 2009 May 1;199(9):1335-44.PMID: 19301979 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.

    Linke MJ, Ashbaugh AD, Demland JA, Walzer PD.

    Respir Res. 2009 Feb 19;10:10.PMID: 19228388 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006.

    Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF.

    Clin Infect Dis. 2008 Feb 15;46(4):625-33.PMID: 18190281 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones.

    Daly KR, Koch JV, Shire NJ, Levin L, Walzer PD.

    Clin Vaccine Immunol. 2006 Oct;13(10):1071-8.PMID: 17028210 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Antibody response to Pneumocystis jirovecii major surface glycoprotein.

    Daly KR, Huang L, Morris A, Koch J, Crothers K, Levin L, Eiser S, Satwah S, Zucchi P, Walzer PD.

    Emerg Infect Dis. 2006 Aug;12(8):1231-7.PMID: 16965702 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.

    Cushion MT, Walzer PD, Ashbaugh A, Rebholz S, Brubaker R, Vanden Eynde JJ, Mayence A, Huang TL.

    Antimicrob Agents Chemother. 2006 Jul;50(7):2337-43.PMID: 16801410 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds.

    Cushion MT, Walzer PD, Collins MS, Rebholz S, Vanden Eynde JJ, Mayence A, Huang TL.

    Antimicrob Agents Chemother. 2004 Nov;48(11):4209-16.PMID: 15504843 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Current epidemiology of Pneumocystis pneumonia.

    Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, Huang L, Beard CB, Kaplan JE.

    Emerg Infect Dis. 2004 Oct;10(10):1713-20. Review.PMID: 15504255 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia.

    Vanden Eynde JJ, Mayence A, Huang TL, Collins MS, Rebholz S, Walzer PD, Cushion MT.

    Bioorg Med Chem Lett. 2004 Sep 6;14(17):4545-8.PMID: 15357989 [PubMed - indexed for MEDLINE]Related articles

    15.

    Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci.

    Daly KR, Koch J, Levin L, Walzer PD.

    Emerg Infect Dis. 2004 May;10(5):848-54.PMID: 15200818 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Sensitized splenocytes result in deleterious cytokine cascade and hyperinflammatory response in rats with Pneumocystis pneumonia despite the presence of corticosteroids.

    Thullen TD, Ashbaugh AD, Daly KR, Linke MJ, Steele PE, Walzer PD.

    Infect Immun. 2004 Feb;72(2):757-65.PMID: 14742518 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies.

    Thullen TD, Ashbaugh AD, Daly KR, Linke MJ, Steele PE, Walzer PD.

    Infect Immun. 2003 Nov;71(11):6292-7.PMID: 14573648 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons.

    Daly KR, Fichtenbaum CJ, Tanaka R, Linke MJ, O'Bert R, Thullen TD, Hui MS, Smulian AG, Walzer PD.

    J Infect Dis. 2002 Sep 1;186(5):644-51. Epub 2002 Aug 9.PMID: 12195351 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia.

    Walzer PD, Ashbaugh A.

    Antimicrob Agents Chemother. 2002 Feb;46(2):514-6.PMID: 11796365 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo.

    Walzer PD, Ashbaugh A, Collins M, Cushion MT.

    J Infect Dis. 2001 Nov 15;184(10):1355-7. Epub 2001 Sep 28. Erratum in: J Infect Dis 2002 Jun 1;185(11):1696. PMID: 11679930 [PubMed - indexed for MEDLINE]Related articles

    22.

    In vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis carinii.

    Walzer PD, Ashbaugh A, Collins M, Cushion MT.

    Antimicrob Agents Chemother. 2001 Nov;45(11):3234-7.PMID: 11600389 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.

    Linke MJ, Harris CE, Korfhagen TR, McCormack FX, Ashbaugh AD, Steele P, Whitsett JA, Walzer PD.

    J Infect Dis. 2001 Mar 15;183(6):943-52. Epub 2001 Feb 15.PMID: 11237812 [PubMed - indexed for MEDLINE]Related articles

    24.

    Geographic clustering of Pneumocystis carinii pneumonia in patients with HIV infection.

    Dohn MN, White ML, Vigdorth EM, Ralph Buncher C, Hertzberg VS, Baughman RP, George Smulian A, Walzer PD.

    Am J Respir Crit Care Med. 2000 Nov;162(5):1617-21.PMID: 11069785 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Immunological features of Pneumocystis carinii infection in humans.

    Walzer PD.

    Clin Diagn Lab Immunol. 1999 Mar;6(2):149-55. Review. No abstract available. PMID: 10066645 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Pneumocystis carinii: a historical perspective.

    Walzer PD.

    Semin Respir Infect. 1998 Dec;13(4):279-82.PMID: 9872623 [PubMed - indexed for MEDLINE]Related articles

    27.

    Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response.

    Theus SA, Smulian AG, Steele P, Linke MJ, Walzer PD.

    Vaccine. 1998 Jul;16(11-12):1149-57.PMID: 9682373 [PubMed - indexed for MEDLINE]Related articles

    28.

    Cell wall antigens of Pneumocystis carinii trophozoites and cysts: purification and carbohydrate analysis of these glycoproteins.

    De Stefano JA, Myers JD, Du Pont D, Foy JM, Theus SA, Walzer PD.

    J Eukaryot Microbiol. 1998 May-Jun;45(3):334-43.PMID: 9627993 [PubMed - indexed for MEDLINE]Related articles

    29.

    Zymolyase treatment exposes p55 antigen of Pneumocystis carinii.

    Broomall KR, Morris RE, Walzer PD, Smulian AG.

    J Eukaryot Microbiol. 1998 May-Jun;45(3):284-9.PMID: 9627988 [PubMed - indexed for MEDLINE]Related articles

    30.

    Comments: overview of the 5th international workshop on Pneumocystis and the 5th general meeting of the European Concerted Action on Pneumocystis Research.

    Kaneshiro ES, Walzer PD.

    J Eukaryot Microbiol. 1997 Nov-Dec;44(6):61S-63S.PMID: 9508446 [PubMed - indexed for MEDLINE]Related articles

    31.

    In vitro cytolytic activity of lymphocytes against Pneumocystis carinii.

    Theus SA, Walzer PD.

    J Eukaryot Microbiol. 1997 Nov-Dec;44(6):25S-27S. No abstract available. PMID: 9508415 [PubMed - indexed for MEDLINE]Related articles

    32.
    33.

    Expression, structure, and location of epitopes of the major surface glycoprotein of Pneumocystis carinii f. sp. carinii.

    Linke MJ, Sunkin SM, Andrews RP, Stringer JR, Walzer PD.

    Clin Diagn Lab Immunol. 1998 Jan;5(1):50-7.PMID: 9455880 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Identification of a putative precursor to the major surface glycoprotein of Pneumocystis carinii.

    Sunkin SM, Linke MJ, McCormack FX, Walzer PD, Stringer JR.

    Infect Immun. 1998 Feb;66(2):741-6.PMID: 9453635 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Terminology for the life cycle of Pneumocystis carinii.

    Cushion MT, Walzer PD, Smulian AG, Linke MJ, Ruffolo JJ, Kaneshiro ES, Stringer JR.

    Infect Immun. 1997 Oct;65(10):4365; author reply 4366. No abstract available. PMID: 9317051 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Pneumocystis carinii pneumonia in patients without human immunodeficiency virus infection.

    Walzer PD.

    Clin Infect Dis. 1997 Aug;25(2):219-20. No abstract available. PMID: 9332514 [PubMed - indexed for MEDLINE]Related articles

    38.

    Cytokine responses to the native and recombinant forms of the major surface glycoprotein of Pneumocystis carinii.

    Theus SA, Smulian AG, Sullivan DW, Walzer PD.

    Clin Exp Immunol. 1997 Aug;109(2):255-60.PMID: 9276520 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii.

    McCormack FX, Festa AL, Andrews RP, Linke M, Walzer PD.

    Biochemistry. 1997 Jul 1;36(26):8092-9.PMID: 9201957 [PubMed - indexed for MEDLINE]Related articles

    40.

    Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii.

    Theus SA, Andrews RP, Linke MJ, Walzer PD.

    J Eukaryot Microbiol. 1997 Mar-Apr;44(2):96-100.PMID: 9109259 [PubMed - indexed for MEDLINE]Related articles

    41.

    Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs.

    Walzer PD, Runck J, Steele P, White M, Linke MJ, Sidman CL.

    Antimicrob Agents Chemother. 1997 Feb;41(2):251-8.PMID: 9021175 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies.

    Walzer PD, Runck J, Orr S, Foy J, Steele P, White M.

    Antimicrob Agents Chemother. 1997 Feb;41(2):242-50.PMID: 9021174 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Closing comments: a retrospective perspective 4th International Workshop on Pneumocystis.

    Cushion MT, Walzer PD.

    J Eukaryot Microbiol. 1996 Sep-Oct;43(5):60S-61S. No abstract available. PMID: 8822859 [PubMed - indexed for MEDLINE]Related articles

    44.

    Molecular biology and epidemiology of Pneumocystis carinii infection in AIDS.

    Stringer JR, Walzer PD.

    AIDS. 1996 Jun;10(6):561-71. Review. No abstract available. PMID: 8780810 [PubMed - indexed for MEDLINE]Related articles

    45.

    Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis.

    Keely SP, Stringer JR, Baughman RP, Linke MJ, Walzer PD, Smulian AG.

    J Infect Dis. 1995 Aug;172(2):595-8.PMID: 7542688 [PubMed - indexed for MEDLINE]Related articles

    46.

    Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat.

    Theus SA, Andrews RP, Steele P, Walzer PD.

    J Clin Invest. 1995 Jun;95(6):2587-93.PMID: 7769101 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.

    Walzer PD, Foy J, Runck J, Steele P, White M, Klein RS, Otter BA, Sundberg RJ.

    Antimicrob Agents Chemother. 1994 Nov;38(11):2572-6.PMID: 7872750 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Analysis of Pneumocystis carinii organism burden, viability and antigens in bronchoalveolar lavage fluid in AIDS patients with pneumocystosis: correlation with disease severity.

    Smulian AG, Linke MJ, Cushion MT, Baughman RP, Frame PT, Dohn MN, White ML, Walzer PD.

    AIDS. 1994 Nov;8(11):1555-62.PMID: 7531457 [PubMed - indexed for MEDLINE]Related articles

    49.

    Production and characterization of monoclonal antibodies specific for the major surface glycoprotein of Pneumocystis carinii.

    Linke MJ, Smulian AG, Yoshihara P, Walzer PD.

    J Eukaryot Microbiol. 1994 Sep-Oct;41(5):99S-100S. No abstract available. PMID: 7804293 [PubMed - indexed for MEDLINE]Related articles

    50.

    Comparison of the antigenic recognition of the major surface glycoprotein of Pneumocystis carinii isolated from different rat strains.

    Andrews RP, Theus SA, Cushion MT, Walzer PD.

    J Eukaryot Microbiol. 1994 Sep-Oct;41(5):72S. No abstract available. PMID: 7804270 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...